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• Intermediate and long acting opioids are given intraoperatively to 
reduce pain during emergence from anesthesia. 
• Recent evidence suggests that intraoperative opioids have 
inconsistent effects on nociception and pain in the immediate 
postoperative period.1,2
• Multiple potent, short-acting opioids such as remifentanil, 
sufentanil and fentanyl1,2 have been shown to produce dose-related 
increases in pain scores and opioid consumption in the immediate 
postoperative recovery period.3
• Intraoperative doses of longer acting opioids such as morphine4,5 
and methadone6 have been shown to reduce pain scores and 
narcotic requirements in the immediate postoperative period. 
• Hydromorphone is an intermediate duration narcotic which is 
commonly used intraoperatively but has not been studied for its 
potential to reduce pain in the immediate postoperative period.4-6
• After Institutional Review Board approval, clinical, demographic, 
and anthropometric data were retrospectively extracted from the 
electronic health records of all patients who underwent total hip or 
knee surgery under general anesthesia at Maine Medical Center 
between 12/3/12 and 5/1/17. 
• Patients were grouped into quartiles based on intraoperative 
hydromorphone dose. 
• Pain scores were routinely assessed in the post anesthesia care unit 
(PACU) using 0-10 numeric rating score (NRS).
• Bivariate analysis was used to identify possible factors associated 
with pain score and narcotic consumption in the PACU for inclusion 
in regression analysis. 
• Ordinal regression analysis was used for assessing impact on pain 
score and analysis of covariance was used for assessing impact on 
narcotic consumption in the post anesthesia care unit (figure 1). 
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Quartile                                           1 2                           3 4
Hydromorphone (μg/kg)  3.95 [0.00-5.54]   6.89 [5.55-8.27]   9.67 [8.29-11.02]   12.97 [11.08-34.45]
• The 3519 surgeries were performed by 3 hip surgeons and 11 knee 
surgeons; variation in maximum PACU NRS among surgeons was 
significant in both groups (p<0.001) 
• The same variables that were significantly associated with maximum 
NRS in PACU were also associated with total opiate dose in PACU.
• Most providers use longer acting narcotics such as hydromorphone, 
morphine or methadone during surgery in part to provide an analgesic 
effect in the early postoperative period. 
• Both morphine4,5 and methadone6 have previously been shown to be 
effective in this regard.
• In our study, increasing intraoperative doses of hydromorphone was 
independently associated with increased maximum pain score and 
opioid dosing in the PACU.
• One possible explanation for a lack of effect of hydromorphone may be 
the timing or the magnitude of the intraoperative doses. It is possible 
that the hydromorphone was given too early or in too small a dose and 
the analgesic effect had worn off. This would not explain the 
paradoxical effect.
• This paradoxical effect could represent acute tolerance (AT) or opioid-
induced hyperalgesia (OIH). Each phenomena is associated with higher 
than expected pain levels and opioid requirements following acute 
opioid administration.
• This is an observational study limited by its retrospective nature. The 
findings were of a very small effect of intra-operative hydromorphone 
dose on post-operative pain scores and opiate consumption that 
reached statistical significance through the large number of cases 
examined. 
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